His scientific interests lie mostly in Microbiology, Antibacterial agent, Pharmacology, Internal medicine and Staphylococcus aureus. Ethan Rubinstein combines subjects such as Piperacillin and Actinobacillus with his study of Microbiology. His Antibacterial agent research is multidisciplinary, incorporating perspectives in Tolerability, Adverse effect, El Niño and Linezolid.
The Internal medicine study combines topics in areas such as Methicillin-resistant Staphylococcus aureus, Surgery, Intensive care, Staphylococcal infections and Vancomycin. His study in Vancomycin is interdisciplinary in nature, drawing from both Bacteremia and Infective endocarditis. His Antibiotics study which covers Meningitis that intersects with Intensive care medicine.
The scientist’s investigation covers issues in Microbiology, Antibiotics, Internal medicine, Antibacterial agent and Surgery. His research in Microbiology intersects with topics in Bacillus anthracis and Staphylococcus aureus. In his study, which falls under the umbrella issue of Antibiotics, Antimicrobial and Infective endocarditis is strongly linked to Intensive care medicine.
Methicillin-resistant Staphylococcus aureus is closely connected to Vancomycin in his research, which is encompassed under the umbrella topic of Internal medicine. Ethan Rubinstein combines subjects such as Ciprofloxacin, Clinical trial, Pediatrics and Pharmacology with his study of Antibacterial agent. He specializes in Surgery, namely Endocarditis.
His primary areas of investigation include Internal medicine, Microbiology, Vancomycin, Antibiotics and Intensive care medicine. The various areas that Ethan Rubinstein examines in his Internal medicine study include Telavancin and Surgery. His Microbiology study combines topics from a wide range of disciplines, such as Ceftazidime and Pharmacology.
His research in Vancomycin focuses on subjects like Bacteremia, which are connected to Retrospective cohort study. His study looks at the relationship between Antibiotics and topics such as Bacillus anthracis, which overlap with Toxin, Levofloxacin, Spore and Protein synthesis inhibitor. His Intensive care medicine research integrates issues from Antimicrobial, Organ dysfunction and Cardiothoracic surgery.
Ethan Rubinstein mainly investigates Pharmacology, Microbiology, Cephalosporin, Ceftazidime and Internal medicine. His Pharmacology study integrates concerns from other disciplines, such as Aerobic bacteria, Staphylococcus aureus, In vivo and Linezolid. His study ties his expertise on Avibactam together with the subject of Microbiology.
The study incorporates disciplines such as Bacteroides fragilis, Minimum inhibitory concentration, Anaerobic bacteria and Cephem in addition to Ceftazidime. Ethan Rubinstein has included themes like Staphylococcal infections and Surgery in his Internal medicine study. The Surgery study combines topics in areas such as Cohort and Intensive care medicine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Staphylococcus aureus Endocarditis A Consequence of Medical Progress
Vance G. Fowler;Jose M. Miro;Bruno Hoen;Christopher H. Cabell.
Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study.
Ethan Rubinstein;Sue K. Cammarata;Thomas H. Oliphant;Richard G. Wunderink.
Clinical Infectious Diseases (2001)
Perspectives for the Treatment of Brucellosis in the 21st Century: The Ioannina Recommendations
Javier Ariza;Mile Bosilkovski;Antonio Cascio;Juan D Colmenero.
PLOS Medicine (2007)
Ceftazidime-avibactam: a novel cephalosporin/β-lactamase inhibitor combination.
George G. Zhanel;George G. Zhanel;Christopher D. Lawson;Heather Adam;Heather Adam;Frank Schweizer.
Association between carriage of Streptococcus pneumoniae and Staphylococcus aureus in Children.
Gili Regev-Yochay;Ron Dagan;Meir Raz;Yehuda Carmeli.
Nasopharyngeal carriage of Streptococcus pneumoniae by adults and children in community and family settings.
Gili Regev-Yochay;Gili Regev-Yochay;Meir Raz;Ron Dagan;Nurith Porat.
Clinical Infectious Diseases (2004)
An Outbreak of Phialemonium Infective Endocarditis Linked to Intracavernous Penile Injections for the Treatment of Impotence
Jacob Strahilevitz;Galia Rahav;Hans Josef Schroers;Richard C. Summerbell.
Clinical Infectious Diseases (2005)
Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence
P. Ball;F. Baquero;O. Cars;T. File.
Journal of Antimicrobial Chemotherapy (2002)
Ceftolozane/Tazobactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination with Activity Against Multidrug-Resistant Gram-Negative Bacilli
George G. Zhanel;George G. Zhanel;Phillip Chung;Heather Adam;Heather Adam;Sheryl Zelenitsky.
Telavancin versus Vancomycin for Hospital-Acquired Pneumonia due to Gram-positive Pathogens
Ethan Rubinstein;Tahaniyat Lalani;G. Ralph Corey;Zeina A. Kanafani.
Clinical Infectious Diseases (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: